Skip to main content
Erschienen in: Immunologic Research 4/2016

15.06.2016 | Original Article

Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy

verfasst von: Rodrigo M. C. Pestana, Caroline P. Domingueti, Rita C. F. Duarte, Rodrigo B. Fóscolo, Janice S. Reis, Ana Maria S. Rodrigues, Laís B. Martins, Lirlândia P. Sousa, Daniela P. Lage, Cláudia N. Ferreira, Adaliene V. M. Ferreira, Ana P. Fernandes, Karina B. Gomes

Erschienen in: Immunologic Research | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of the present study was to investigate the association between the presence of albuminuria and cytokines profile with biomarkers of endothelial damage and oxidative stress in patients with type 1 diabetes mellitus (DM1). The sample was composed by 35 healthy individuals, 63 DM1 patients with normoalbuminuria (<30 mg of albumin/g of creatinine) and 62 DM1 patients with micro- and macroalbuminuria (≥30 mg of albumin/g of creatinine). Plasma and urinary cytokines (TNF-α, IL-6 and IL-10) and thrombomodulin levels were determined by ELISA. Oxidative status was evaluated using the TBARS and MTT assays. Diabetic patients were characterized by elevated levels of urinary cytokines TNF-α, IL-6 and IL-10. Those with macroalbuminuria presented significantly higher TNF-α and IL-10 urinary levels when compared to other groups. Urinary and plasmatic levels of TNF-α were positively correlated with plasma levels of cystatin C, creatinine, urea and albuminuria, while they were negatively correlated with estimated glomerular filtration rate. Urinary IL-10 levels proved positive correlation with fasting glucose, HbA1c, thrombomodulin and TBARS, while IL-6 plasma levels were positively correlated with HbA1c and albuminuria. Only urinary TNF-α levels were associated with the presence and severity of macroalbuminuria, after logistic regression analysis. This finding suggests that measurement of urinary TNF-α level may be helpful to evaluate progression to nephropathy in DM1 patients.
Literatur
1.
Zurück zum Zitat Gross JL, Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:176–88.CrossRef Gross JL, Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:176–88.CrossRef
2.
Zurück zum Zitat National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S12–154.CrossRef National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S12–154.CrossRef
3.
Zurück zum Zitat Cvetković T, Mitić B, Lazarević G, Vlahović P, Antić S, Stefanović V. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. J Diabetes Complic. 2009;23:337–42.CrossRef Cvetković T, Mitić B, Lazarević G, Vlahović P, Antić S, Stefanović V. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. J Diabetes Complic. 2009;23:337–42.CrossRef
4.
Zurück zum Zitat Wu Y, Dong J, Yuan L, Liang C, Ren K, Zhang W, et al. Cytokine Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine. 2008;44:85–91.CrossRefPubMed Wu Y, Dong J, Yuan L, Liang C, Ren K, Zhang W, et al. Cytokine Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine. 2008;44:85–91.CrossRefPubMed
5.
Zurück zum Zitat Cherney DZI, Scholey JW, Daneman D, Dunger DB, Dalton RN, Moineddin R, et al. Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria. Diabet Med. 2012;29:1297–302.CrossRefPubMed Cherney DZI, Scholey JW, Daneman D, Dunger DB, Dalton RN, Moineddin R, et al. Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria. Diabet Med. 2012;29:1297–302.CrossRefPubMed
6.
Zurück zum Zitat Utimura R, Fujihara CK, Mattar AL, Malheiros DMA, Noronha IL, Zatz R. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int. 2003;63:209–16.CrossRefPubMed Utimura R, Fujihara CK, Mattar AL, Malheiros DMA, Noronha IL, Zatz R. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int. 2003;63:209–16.CrossRefPubMed
7.
Zurück zum Zitat Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, et al. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Diabetologia. 2005;48:2402–11.CrossRefPubMed Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, et al. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Diabetologia. 2005;48:2402–11.CrossRefPubMed
8.
Zurück zum Zitat Rivero A, Mora C, Muros M, Garc J. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci. 2009;492:479–92.CrossRef Rivero A, Mora C, Muros M, Garc J. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci. 2009;492:479–92.CrossRef
9.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes: 2015. Diabetes Care. 2015;38:59–67.CrossRef American Diabetes Association. Standards of medical care in diabetes: 2015. Diabetes Care. 2015;38:59–67.CrossRef
10.
11.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.CrossRefPubMed
12.
Zurück zum Zitat Dotan Y, Lichtenberg D, Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res. 2004;43:200–27.CrossRefPubMed Dotan Y, Lichtenberg D, Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res. 2004;43:200–27.CrossRefPubMed
13.
Zurück zum Zitat Duarte RCF, Campos FMF, Filho OAM, Alves MT, Fernandes AP, Borges KBG, et al. Effect of acetylsalicylic acid on platelet activation and oxidative profile in a set of Brazilian patients with type 2 diabetes mellitus. Blood Coagul Fibrinolysis. 2015;26:123–30.CrossRefPubMed Duarte RCF, Campos FMF, Filho OAM, Alves MT, Fernandes AP, Borges KBG, et al. Effect of acetylsalicylic acid on platelet activation and oxidative profile in a set of Brazilian patients with type 2 diabetes mellitus. Blood Coagul Fibrinolysis. 2015;26:123–30.CrossRefPubMed
14.
Zurück zum Zitat Medina LO, Veloso CA, Borges EA, Isoni CA, Calsolari MR, Chaves MM, et al. Determination of the antioxidant status of plasma from type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77:193–7.CrossRefPubMed Medina LO, Veloso CA, Borges EA, Isoni CA, Calsolari MR, Chaves MM, et al. Determination of the antioxidant status of plasma from type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77:193–7.CrossRefPubMed
15.
Zurück zum Zitat Lampropoulou I, Stangou M, Papagianni A, Didangelos T, Iliadis F, Efstratiadis G. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. J Diabetes Res. 2014;2014:1–7.CrossRef Lampropoulou I, Stangou M, Papagianni A, Didangelos T, Iliadis F, Efstratiadis G. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. J Diabetes Res. 2014;2014:1–7.CrossRef
16.
Zurück zum Zitat Ruotsalainen E, Stancakova A, Vauhkonen I, Salmenniemi U, Pihlajamaki J, Punnonen K, et al. Changes in cytokine levels during acute hyperinsulinemia in offspring of type 2 diabetic subjects. Atherosclerosis. 2010;210:536–41.CrossRefPubMed Ruotsalainen E, Stancakova A, Vauhkonen I, Salmenniemi U, Pihlajamaki J, Punnonen K, et al. Changes in cytokine levels during acute hyperinsulinemia in offspring of type 2 diabetic subjects. Atherosclerosis. 2010;210:536–41.CrossRefPubMed
17.
Zurück zum Zitat Domingueti CP, Fóscolo RB, Reis JS, Magalhães F, Campos F, Dusse LMS, et al. Association of haemostatic and inflammatory biomarkers with nephropathy in type 1 diabetes mellitus. J Diabetes Res. 2016;2016:1–8.CrossRef Domingueti CP, Fóscolo RB, Reis JS, Magalhães F, Campos F, Dusse LMS, et al. Association of haemostatic and inflammatory biomarkers with nephropathy in type 1 diabetes mellitus. J Diabetes Res. 2016;2016:1–8.CrossRef
18.
Zurück zum Zitat Kalantarinia K, Awad AS, Siragy HM. Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats. Kidney Int. 2003;64:1208–13.CrossRefPubMed Kalantarinia K, Awad AS, Siragy HM. Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats. Kidney Int. 2003;64:1208–13.CrossRefPubMed
19.
Zurück zum Zitat DiPetrillo K, Coutermarsh B, Gesek FA. Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol. 2003;284:113–21.CrossRef DiPetrillo K, Coutermarsh B, Gesek FA. Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol. 2003;284:113–21.CrossRef
20.
Zurück zum Zitat Ng DP, Fukushima M, Tai BC, Koh D, Leong H, Imura H, et al. Reduced GFR and albuminuria in Chinese type 2 diabetes mellitus patients are both independently associated with activation of the TNF-alpha system. Diabetologia. 2008;51:2318–24.CrossRefPubMed Ng DP, Fukushima M, Tai BC, Koh D, Leong H, Imura H, et al. Reduced GFR and albuminuria in Chinese type 2 diabetes mellitus patients are both independently associated with activation of the TNF-alpha system. Diabetologia. 2008;51:2318–24.CrossRefPubMed
21.
Zurück zum Zitat Sun L, Kanwar YS. Relevance of TNF- α in the context of other inflammatory cytokines in the progression of diabetic nephropathy. Kidney Int. 2015;88:662–5.CrossRefPubMedPubMedCentral Sun L, Kanwar YS. Relevance of TNF- α in the context of other inflammatory cytokines in the progression of diabetic nephropathy. Kidney Int. 2015;88:662–5.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Manda G, Checherita A, Comanescu MV, Hinescu ME. Redox signaling in diabetic nephropathy: hypertrophy versus death choices in mesangial cells and podocytes. Mediators Inflamm. 2015;2015:1–13.CrossRef Manda G, Checherita A, Comanescu MV, Hinescu ME. Redox signaling in diabetic nephropathy: hypertrophy versus death choices in mesangial cells and podocytes. Mediators Inflamm. 2015;2015:1–13.CrossRef
23.
Zurück zum Zitat Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677–86.CrossRefPubMed Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677–86.CrossRefPubMed
24.
Zurück zum Zitat Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol. 2006;17:368–77.CrossRefPubMed Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol. 2006;17:368–77.CrossRefPubMed
25.
Zurück zum Zitat Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism. 2003;52:605–8.CrossRefPubMed Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism. 2003;52:605–8.CrossRefPubMed
26.
Zurück zum Zitat Awad AS, You H, Gao T, Cooper TK, Nedospasov SA, Vacher J, et al. Macrophage-derived tumor necrosis factor-alpha mediates diabetic renal injury. Kidney Int. 2015;88:722–33.CrossRefPubMedPubMedCentral Awad AS, You H, Gao T, Cooper TK, Nedospasov SA, Vacher J, et al. Macrophage-derived tumor necrosis factor-alpha mediates diabetic renal injury. Kidney Int. 2015;88:722–33.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Hirayama K, Ebihara I, Yamamoto S, Kai H, Muro K, Yamagata K, et al. Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis. Nephron. 2002;91:255–61.CrossRefPubMed Hirayama K, Ebihara I, Yamamoto S, Kai H, Muro K, Yamagata K, et al. Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis. Nephron. 2002;91:255–61.CrossRefPubMed
28.
Zurück zum Zitat Sinuani I, Beberashvili I, Averbukh Z, Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant. 2013;3(4):91–8.PubMedPubMedCentral Sinuani I, Beberashvili I, Averbukh Z, Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant. 2013;3(4):91–8.PubMedPubMedCentral
29.
Zurück zum Zitat Cove-Smith A, Hendry BM. The regulation of mesangial cell proliferation. Nephron Exp Nephrol. 2008;108(4):e74–9.CrossRefPubMed Cove-Smith A, Hendry BM. The regulation of mesangial cell proliferation. Nephron Exp Nephrol. 2008;108(4):e74–9.CrossRefPubMed
30.
Zurück zum Zitat Rafiq K, Charitidou L, Bullens DM, et al. Regulation of the IL-10 production by human T cells. Scand J Immunol. 2001;53(2):139–47.CrossRefPubMed Rafiq K, Charitidou L, Bullens DM, et al. Regulation of the IL-10 production by human T cells. Scand J Immunol. 2001;53(2):139–47.CrossRefPubMed
31.
Zurück zum Zitat Wong CK, Ho AWY, Tong PCY, Yeung CY, Kong APS, Lun SWM, et al. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clin Exp Immunol. 2007;149:123–31.CrossRefPubMedPubMedCentral Wong CK, Ho AWY, Tong PCY, Yeung CY, Kong APS, Lun SWM, et al. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clin Exp Immunol. 2007;149:123–31.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Mysliwska J, Zorena K, Semetkowska-Jurkiewicz E, Rachon D, Suchanek H, Mysliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw. 2005;16:117–22.PubMed Mysliwska J, Zorena K, Semetkowska-Jurkiewicz E, Rachon D, Suchanek H, Mysliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw. 2005;16:117–22.PubMed
33.
Zurück zum Zitat Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med. 2007;13:1349–58.CrossRefPubMed Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med. 2007;13:1349–58.CrossRefPubMed
34.
Zurück zum Zitat Wang H, Vinnikov I, Shahzad K, Bock F, Ranjan S, Wolter J, et al. The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition. Thromb Haemost. 2012;108:1141–53.CrossRefPubMed Wang H, Vinnikov I, Shahzad K, Bock F, Ranjan S, Wolter J, et al. The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition. Thromb Haemost. 2012;108:1141–53.CrossRefPubMed
35.
Zurück zum Zitat Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003;149:1–38.PubMed Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003;149:1–38.PubMed
36.
Zurück zum Zitat Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes. 2005;54(Suppl 2):S114–24.CrossRefPubMed Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes. 2005;54(Suppl 2):S114–24.CrossRefPubMed
37.
Zurück zum Zitat Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006;63(5):321–9.CrossRefPubMed Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006;63(5):321–9.CrossRefPubMed
38.
Zurück zum Zitat Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Garcia-Perez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011;7:327–40.CrossRefPubMed Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Garcia-Perez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011;7:327–40.CrossRefPubMed
39.
Zurück zum Zitat Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest. 2001;107:217–24.CrossRefPubMedPubMedCentral Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest. 2001;107:217–24.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Dalla Vestra M, Mussap M, Gallina P, Bruseghin M, Cernigoi AM, Saller A, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16(Suppl 1):S78–82.CrossRef Dalla Vestra M, Mussap M, Gallina P, Bruseghin M, Cernigoi AM, Saller A, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16(Suppl 1):S78–82.CrossRef
41.
Zurück zum Zitat Rinno T, Kuramoto T, Iijima M, Yagame Y. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy. J Clin Lab Anal. 1996;10:119–24.CrossRefPubMed Rinno T, Kuramoto T, Iijima M, Yagame Y. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy. J Clin Lab Anal. 1996;10:119–24.CrossRefPubMed
42.
Zurück zum Zitat Shimano H, Takahashi K, Kawakami M, Gotoda T, Harada K, Shimada M, et al. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus. Clin Chim Acta. 1994;225:89–96.CrossRefPubMed Shimano H, Takahashi K, Kawakami M, Gotoda T, Harada K, Shimada M, et al. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus. Clin Chim Acta. 1994;225:89–96.CrossRefPubMed
43.
Zurück zum Zitat Hirano T, Ookubo K, Kashiwazaki K, Tajima H, Yoshino G, Adachi M. Vascular endothelial markers, von willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease. Clin Chim Acta. 2000;299:65–75.CrossRefPubMed Hirano T, Ookubo K, Kashiwazaki K, Tajima H, Yoshino G, Adachi M. Vascular endothelial markers, von willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease. Clin Chim Acta. 2000;299:65–75.CrossRefPubMed
44.
Zurück zum Zitat Okumura K, Aso Y. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy. Metabolism. 2003;52:1517–22.CrossRefPubMed Okumura K, Aso Y. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy. Metabolism. 2003;52:1517–22.CrossRefPubMed
45.
Zurück zum Zitat Von Scholten BJ, Reinhard H, Hansen TW, et al. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria. J Diabetes Complicat. 2016;30(2):248–55.CrossRef Von Scholten BJ, Reinhard H, Hansen TW, et al. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria. J Diabetes Complicat. 2016;30(2):248–55.CrossRef
46.
Zurück zum Zitat Bao Y, Jia X, Wang D, Liu R, Zou C, Na S. Characterization of soluble thrombomodulin levels in patients with stage 3–5 chronic kidney disease. Biomarkers. 2014;19(4):275–80.CrossRefPubMed Bao Y, Jia X, Wang D, Liu R, Zou C, Na S. Characterization of soluble thrombomodulin levels in patients with stage 3–5 chronic kidney disease. Biomarkers. 2014;19(4):275–80.CrossRefPubMed
47.
Zurück zum Zitat Yang S, Ka S, Wu H, Yeh Y, Kuo C, Hua K, et al. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis. Diabetologia. 2014;57:424–34.CrossRefPubMed Yang S, Ka S, Wu H, Yeh Y, Kuo C, Hua K, et al. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis. Diabetologia. 2014;57:424–34.CrossRefPubMed
48.
Zurück zum Zitat Shi CS, Shi GY, Hsiao HM, Kao YC, Kuo KL, Ma CY, et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood. 2008;112:3661–70.CrossRefPubMedPubMedCentral Shi CS, Shi GY, Hsiao HM, Kao YC, Kuo KL, Ma CY, et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood. 2008;112:3661–70.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaβ and mitogen-activated protein kinase pathways. J Exp Med. 2002;196:565–77.CrossRefPubMedPubMedCentral Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaβ and mitogen-activated protein kinase pathways. J Exp Med. 2002;196:565–77.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ann Clin Biochem. 2005;42:99–104.CrossRefPubMed Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ann Clin Biochem. 2005;42:99–104.CrossRefPubMed
51.
Zurück zum Zitat Yilmaz G, Yilmaz FM, Aral Y, Yucel D. Levels of serum sialic acid and thiobarbituric acid reactive substances in subjects with impaired glucose tolerance and type 2 diabetes mellitus. J Clin Lab Anal. 2007;21:260–4.CrossRefPubMed Yilmaz G, Yilmaz FM, Aral Y, Yucel D. Levels of serum sialic acid and thiobarbituric acid reactive substances in subjects with impaired glucose tolerance and type 2 diabetes mellitus. J Clin Lab Anal. 2007;21:260–4.CrossRefPubMed
52.
Zurück zum Zitat Afshari AT, Shirpoor A, Farshid A, Saadatian R, Rasmi Y, Saboory E, et al. The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats. Food Chem. 2007;101:148–53.CrossRef Afshari AT, Shirpoor A, Farshid A, Saadatian R, Rasmi Y, Saboory E, et al. The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats. Food Chem. 2007;101:148–53.CrossRef
53.
Zurück zum Zitat Medina-Navarro R, Corona-Candelas I, Barajas-Gonzalez S, Diaz-Flores M, Duran-Reyes G. Albumin antioxidant response to stress in diabetic nephropathy progression. PLoS ONE. 2014;9:e106490.CrossRefPubMedPubMedCentral Medina-Navarro R, Corona-Candelas I, Barajas-Gonzalez S, Diaz-Flores M, Duran-Reyes G. Albumin antioxidant response to stress in diabetic nephropathy progression. PLoS ONE. 2014;9:e106490.CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Medina-Navarro R, Duran-Reyes G, Diaz-Flores M, Vilar-Rojas C. Protein antioxidant response to the stress and the relationship between molecular structure and antioxidant function. PLoS ONE. 2010;5:e8971.CrossRefPubMedPubMedCentral Medina-Navarro R, Duran-Reyes G, Diaz-Flores M, Vilar-Rojas C. Protein antioxidant response to the stress and the relationship between molecular structure and antioxidant function. PLoS ONE. 2010;5:e8971.CrossRefPubMedPubMedCentral
Metadaten
Titel
Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy
verfasst von
Rodrigo M. C. Pestana
Caroline P. Domingueti
Rita C. F. Duarte
Rodrigo B. Fóscolo
Janice S. Reis
Ana Maria S. Rodrigues
Laís B. Martins
Lirlândia P. Sousa
Daniela P. Lage
Cláudia N. Ferreira
Adaliene V. M. Ferreira
Ana P. Fernandes
Karina B. Gomes
Publikationsdatum
15.06.2016
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 4/2016
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-016-8806-x

Weitere Artikel der Ausgabe 4/2016

Immunologic Research 4/2016 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.